Literature DB >> 19399503

Higher genetic susceptibility to inflammation in mild disease activity of systemic lupus erythematosus.

Li-Jen Tsai1, Sheng-Hsiung Hsiao, Jaw-Ji Tsai, Ching-Yuang Lin, Lih-Min Tsai, Joung-Liang Lan.   

Abstract

In order to test the hypothesis that stratification of Mexican Modification of the Systemic Lupus Erythematosus Disease Activity Index (MEX-SLEDAI) simplifies the genetic study of SLE, we evaluated the genetic susceptibility to inflammation and defects in clearance of immune complexes among SLE patients in Taiwan. SLE phenotypes were stratified according to the MEX-SLEDAI scores into two subgroups (<or=10 and >10), and then according to renal disorder and neurological disorder, aiming to minimize any loss of power associated with disease heterogeneity. Upon stratification, IL1-beta polymorphism and LTA were significantly associated with SLE within the MEX-SLEDAI <or=10 subgroup. When SLE patients were classified into two subgroups with or without renal disorder to stratify the genetic study, we could find that the stratification with renal disorder could partially confirm the hypothesis that stratification of MEX-SLEDAI score simplifies the genetic study of complex diseases such as SLE. So we concluded that in the mild disease state of SLE, stratification of disease phenotypes, especially IL1-beta and LTA, according to MEX-SLEDAI scores could reveal new associations between candidate genes and disease activity index of SLE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19399503     DOI: 10.1007/s00296-009-0900-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  50 in total

1.  Analysis of polymorphisms affecting immune complex handling in systemic lupus erythematosus.

Authors:  K E Sullivan; A F Jawad; L M Piliero; N Kim; X Luan; D Goldman; M Petri
Journal:  Rheumatology (Oxford)       Date:  2003-03       Impact factor: 7.580

2.  The different expression patterns of interleukin-1 receptor antagonist in systemic lupus erythematosus.

Authors:  L-J Tsai; J-L Lan; C-Y Lin; S-H Hsiao; L-M Tsai; J-J Tsai
Journal:  Tissue Antigens       Date:  2006-12

3.  Family and twin studies in systemic lupus erythematosus.

Authors:  D M Grennan; A Parfitt; N Manolios; Q Huang; V Hyland; H Dunckley; T Doran; P Gatenby; C Badcock
Journal:  Dis Markers       Date:  1997-04       Impact factor: 3.434

4.  Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus.

Authors:  A Studnicka-Benke; G Steiner; P Petera; J S Smolen
Journal:  Br J Rheumatol       Date:  1996-11

Review 5.  Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease.

Authors:  David Botstein; Neil Risch
Journal:  Nat Genet       Date:  2003-03       Impact factor: 38.330

6.  Effect of environmental changes on oxidative deoxyribonucleic acid (DNA) damage in systemic lupus erythematosus.

Authors:  Etsuko Maeshima; Xiang-Ming Liang; Haruhisa Otani; Masatoshi Mune; Susumu Yukawa
Journal:  Arch Environ Health       Date:  2002 Sep-Oct

7.  Nucleotide variation, haplotype structure, and association with end-stage renal disease of the human interleukin-1 gene cluster.

Authors:  Jeannette T Bensen; Carl D Langefeld; Gregory A Hawkins; Linda E Green; Josyf C Mychaleckyj; Catherine S Brewer; Deborah S Kiger; Scott M Binford; Carla J Colicigno; Dax C Allred; Barry I Freedman; Donald W Bowden
Journal:  Genomics       Date:  2003-08       Impact factor: 5.736

8.  Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States.

Authors:  C G Parks; G S Cooper; M A Dooley; E L Treadwell; E W St Clair; G S Gilkeson; J P Pandey
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

9.  Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses.

Authors:  Frann Bennett; Deborah Luxenberg; Vincent Ling; I-Ming Wang; Kim Marquette; David Lowe; Nighat Khan; Geertruida Veldman; Kenneth A Jacobs; Viia E Valge-Archer; Mary Collins; Beatriz M Carreno
Journal:  J Immunol       Date:  2003-01-15       Impact factor: 5.422

10.  Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis.

Authors:  Fotini B Karassa; Thomas A Trikalinos; John P A Ioannidis
Journal:  Arthritis Rheum       Date:  2002-06
View more
  2 in total

1.  Interleukin-1 gene cluster and IL-1 receptor polymorphisms in Iranian patients with systemic lupus erythematosus.

Authors:  Zahra Tahmasebi; Mahmoud Akbarian; Sedigheh Mirkazemi; Abtin Shahlaee; Zahra Alizadeh; Ali Akbar Amirzargar; Ahmad Reza Jamshidi; Shima Ghoroghi; Shiva Poursani; Keramat Nourijelyani; Mahdi Mahmoudi
Journal:  Rheumatol Int       Date:  2013-05-31       Impact factor: 2.631

2.  Polymorphisms in the TNFA and IL6 genes represent risk factors for autoimmune thyroid disease.

Authors:  Cecília Durães; Carla S Moreira; Inês Alvelos; Adélia Mendes; Liliana R Santos; José Carlos Machado; Miguel Melo; César Esteves; Celestino Neves; Manuel Sobrinho-Simões; Paula Soares
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.